Many isolates belonging to the Enterobacteriaceae were collected in 1965 from the inpatients at geographically scattered hospitals in Japan. Among 2,650 Shigella strains examined, 58.4% were found to be drug-resistant; 95.0% of these resistant strains were multiply resistant. Among 434 resistant strains examined, 81 % carried R factors that were transferable by cell-to-cell contact. Of 160 isolates of other enteric bacteria, drug-resistant strains included 84.2% of the Escherichia coli, 93.0% of the Klebsiella, and 90.0% of the Proteus cultures. Among these resistant strains, 70.3% of the E. coli, 66.7% of the Klebsiella, and 52.0% of the Proteus were multiply resistant. Of these resistant strains, 84.0% of the E. coli, 88.0% of the Klebsiella, and 50.0% of the Proteus strains carried R factors. These results indicate that R factors are widespread among gram-negative bacteria of clinical significance.
It was found in Japan that drug resistance was transferred between Shigella and Escherichia coli by mixed cultivation (1, 14) . This transfer was not mediated by a filterable agent as are the phenomena of transduction and transformation, but required cell-to-cell contact, i.e., conjugation (8) . The transmissible drug resistance could be lost spontaneously or eliminated by treatment with acridine dyes (11) (12) (13) . Hence, these genetic de- terminants share many of the properties of bacterial episomes or plasmids and the term "R" (resistance) was proposed for this transmissible property (5) .
It is known that the R factor is transferred to many gram-negative bacteria, including most genera of the Enterobacteriaceae (4 Media. Brain Heart Infusion (BHI; Difco) was used as propagating media for R-factor transfer. Heart Infusion Agar (Difco) was used for the assay of drug resistance. AL-agar medium and Salmonella-Shigella agar medium were used for selection of recipients that had acquired the R factor. The AL-agar medium consisted of 1,000 ml of medium A (3), 20 g of lactose, 40 ml of 0.2% bromothymol blue, and 13 g of agar.
Drugs. Chloramphenicol (CM), tetracycline (TC), dihydrostreptomycin (SM), sulfonamide (SA), kanamycin (KM), fradiomycin (FM), aminobenzylpenicillin (ABPC), cephalothin, colistin, paromomycin, dextromycin, gentamicin, furatoridin, furazoridon, and nalidixic acid (NA) were used as working standards for the assay of resistance (supplied by H. Umezawa, Department of Antibiotics, National Institute of Health, Tokyo, Japan).
Drug resistance. Resistance of the organisms was determined by the method described previously (4) and was expressed as the maximal concentration allowing bacterial growth. Mueller Hinton Medium (Difco) was used for the determination of SA resistance.
Transfer ofR factor. E. coli K-12 W3630 and E. coli 0-26 were used as the recipients of the R factor from Shigella strains; 0.1 ml of an overnight BHI broth culture of each donor (Shigella) and recipient were mixed and inoculated in 1 ml of fresh BHI broth. After incubation for 18 hr at 37 C, 0.1 ml of the appropriately diluted culture was spread on AL-agar plates containing CM (25 ,Ag/ml), TC (25 ,ug/ml), SM (12.5 ,ug/ml), or SA (200 ,g/ml). The mixed culture had a viable count of about 2 X 109 organisms per milliliter. After 2 days of incubation at 37 C, each of the colonies which developed on the selective plates was picked, and its drug resistance was determined after two successive single-colony isolations.
Salmonella typhi S-57 was used as a recipient for the R factor from the strains of E. coli, Klebsiella pneumoniae, and Proteus mirabilis. Salmonella-Shigella agar containing CM (25 ,ug/ml), TC (25 ,ug/ml), or SM (12.5 ,ug/ml) was used for selection. The mixed cultivation of donor and recipient strains for the transfer of R factor was the same as described above.
Ability to transfer the R factor was investigated by mixed cultivation of E. coli W3630 (NA-resistant) with those recipients which had acquired the R factor from the tested strains. Heart Infusion Agar containing NA (50,ug/ml) and CM (25 ,sg/ml), TC (25 gg/ml), or SM (12.5 ,g/ml) was used as the selective medium. AL-plates containing NA (25 ,ug/ml) and SA (200,ug/ml) were used as a selective medium when SA was the selective marker.
RESULTS
Among 2,560 Shigella strains examined, 58.4%, were found to be drug-resistant; 95.0% of the resistant strains were multiply resistant. The details of cross-resistance will be described elsewhere. The distribution of R factors among the resistant shigellae was investigated by using 434 resistant strains; 81 % of these were found to carry R factors transferable by mixed cultivation (Table 1) The production of antibiotics such as SM, TC, and CM started in Japan around 1951, and these agents were quite effective against dysentery. The antibiotic resistant-Shigella strains have appeared with the increased production of these antibiotics. However, antibiotic-resistant isolates were few in number between 1951 and 1955, with just 7, 11, and 4 isolates resistant to SM or TC reported in Japan in 1953, 1954 , and 1955, respectively (6, 7, 9) .
The first isolation of a multiply resistant Shigella strain occurred in 1955 (9) . This multiple resistance involved TC, SM, CM, and SA. Thereafter, the isolation frequency of multiply resistant strains increased rapidly, reaching 95.0%70 in 1965.
The isolation frequency of Shigella strains resistant to drugs other than TC, SM, CM, and SA was still very low in 1965. (AB-PC and NA resistance were only 0.35 and 0.24%, respectively.)
The results of these studies on the distribution of R factors in Shigella isolates in Japan have indicated that the wide distribution and rapid increase of resistant Shigella strains, especially of multiply resistant isolates, can be ascribed primarily to the appearance and distribution of Shigella strains carrying R factors.
The data concerning the drug resistance of other gram-negative bacteria, including E. coli, Klebsiella, and Proteus, are very limited. In 1957,
we isolated E. coli strains resistant to TC, CM, SM, and SA during an epidemic caused by S. flexneri 3a resistant to these four drugs (9, 10) . Also, in 1958 we isolated an E. coli strain resistant to CM, SM, and SA from a patient infected with S. flexneri 2a, a strain resistant to the same agents. From another patient, S. flexneri 2a, E. coli, and E. freundii strains resistant to TC, CM, SM, and SA were isolated (9). These observations stimulated our interest in the origin and genetics of this multiple resistance.
A previous paper (10) from our laboratory showed that 1.4%, of 1,145 healthy human subjects carried multiply resistant E. coli. Another survey in 1960 also disclosed that 1.3% of healthy human subjects carried multiply resistant E. coli (10) . In contrast, 58.9% of inpatients treated with chloramphenicol, and 20.5% of inpatients with tuberculosis, carried multiply resistant E. coli (10 (2, 15) indicate that R factors are now widespread all over the world.
The origin of the R factor is quite obscure. It was suggested that a transfer factor picked up resistance genes from the chromosome of bacteria step by step, increasing the resistance genes from one to two, from two to three, and so on (16) .
According to our data, the first isolation of R(TC . CM. SM. SA) factor, which is isolated most frequently, can not be traced back earlier than 1955, despite the extensive use of sulfanilamide since 1945 and of SM, TC, and CM since 1950. Consequently, one of us postulated that R factors have not appeared with increasing numbers and types of resistance genes, but rather all at once with TC.CM.SM.SA resistance (6, 7) .
